Equine metabolic syndrome Pathophysiology Flashcards
What is equine metabolic syndrome?
Not a single disease, but a collection of risk factors for endocrinopathic laminitis
* Insulin dysregulation
* Prolonged hyperinsulinaemic response
* Postprandial
* Basal hyperinsulinaemia
* +/- hyperglycaemia
* Tissue insulin resistance
* Obesity (there are also lean animals with EMS)
* Laminitis
What are the components of insulin dysregulation?
Why is hyperinsulinaemia the most important factor? How can we reduce insulin concentration?
- Predictive of laminitis risk
- Hyperinsulinaemia is also causative of laminitis
- Therefore, reducing insulin concentration is key
- Diet
- Exercise
- Medication
Why is there not a set limit for insulin concentration that mean a horse will get laminitis?
No set insulin concentration -> laminitis
* Genetics
* Age
* Bodyweight
* Previous bouts of laminitis
Is EMS like diabetes?
No… EMS =/= diabetes
However, prolonged high insulin can cause pancreatic beta cell exhaustion (not common)
* Hyperglycaemia
* PU/PD
* Weight loss
* Normal insulin concentration
Why is pathophysiology important?
Diagnostic testing
- who to test
- which test to select
- what am i actually testing
Understanding laminitis risk
Management
What are risk factors for EMS?
- Genetically predisposed breeds
- Native breed ponies
- Spanish-derived breeds
- Warmbloods
- Obesity/regional adiposity
- Pregnancy associated ID
- With or without hyperinsulinaemia
What clinical signs are associated with EMS?
- ‘Easy keeper’/’good doer’
- Regional adiposity
- Cresty neck
- ‘Fat pads’
- Sheath/mammary gland swelling
- Laminitis
- Divergent hoof rings
What tests can you do to diagnose EMS?
Basal tests
* Basal insulin concentration - not sensitive
* Do not fast beforehand
* 1-3 hours after coming off pasture
* Not after big feed
* Can be used to assess response to diet change
* Adiponectin
* Adipose derived, insulin-sensitising hormone
* Low concentration associated with laminitis risk
Dynamic tests
* Oral sugar test (OST)
* (collect baseline insulin – optional)
* Administer oral Karo Light syrup (45 ml/100kg bwt)
* 60-90 min later collect blood – insulin and glucose
* Combined glucose insulin test (CGIT)
* Fast overnight, collect baseline insulin and glucose
* Administer IV glucose and insulin
* Frequent glucose sampling, insulin at 45min
* Glucose should be at baseline by 45min, insulin <100 iu/ml
* Similar to insulin tolerance test (ITT)
What are you testing with the different diagnostic tests?
Insulin dysregulation:
* Prolonged hyperinsulinaemic response (OST or CGIT)
* Basal hyperinsulinaemia (Basal insulin concentration)
* +/- hyperglycaemia
* Tissue insulin resistance (CGIT)
Why would you choose oral vs IV dynamic tests?
- Oral administration of glucose stimulates more insulin secretion than intravenous administration
- Oral administration simulates ‘real life’ more closely
- Oral glucose affected by other factors
- Gastric emptying/gut transit
- Absorption etc.
- CGIT cuts out enteroinsular axis
What is the enteroinsular axis?
Ingestion of glucose -> incretins -> stimulate insulin release
* Gastric inhibitory peptide (GIP)
* GLP-1 - stimulates insulin release
* GLP-2 - increases glucose availability
Diet high in non structural carbohydrates decreases insulin sensitivity and ↓ adiponectin (insulin sensitising hormone)
Why does laminitis occur?
- Hyperinsulinaemia causes laminitis
- Lengthening/stretching of secondary epidermal lamellae
- Different to sepsis related laminitis
- No destruction of basement membrane
- Different to sepsis related laminitis
IGF 1 upregulation changes musculoskeletal strength but multifactorial
How can we assess risk of laminitis?
- Identify hyperinsulinaemia
- Dynamic tests
- Decreased apidonectin concentration
- Assess for concurrent risk factors
- E.g. PPID
- Evidence of previous episodes
- ‘Footy’
- Divergent hoof rings
How should you manage horses with EMS?
Diet
* Reduce carbohydrate intake - soaked hay
* Manage obesity
Exercise
* Increases insulin sensitivity
* Helps manage obesity to a degree
Medication
* SGLT2 inhibitors (ertugliflozin, canagliflozin)
* (Others e.g. levothryoxin)